Responses of the urinary excretion of homovanillic acid and of 5-hydroxy-indol-acetic acid to treatment with L-dopa and amantadine.
D000547:Amantadine / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine*; D010300:Parkinson Disease / Q000188:drug therapy / Q000652:urine; D010648:Phenylacetates / Q000652:urine*
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D006719:Homovanillic Acid